Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents for consultation regarding MTF breast augmentation. Patient reports [duration] of gender-affirming hormone therapy (GAHT) with [regimen/duration]. Patient expresses dissatisfaction with current breast volume and contour, desiring surgical intervention to achieve a more feminine chest aesthetic. No history of breast malignancy. Patient demonstrates realistic expectations and understands the limitations of surgical outcomes.
Clinical Examination Findings
Physical examination reveals a [Tanner Stage] breast development. Chest wall anatomy is noted for [width/symmetry/pectoralis muscle prominence]. Skin quality is [elasticity/texture]. No palpable masses, lymphadenopathy, or nipple discharge noted. Nipple-areolar complex (NAC) position is [symmetrical/asymmetrical]. Chest wall deformity or pectus excavatum/carinatum is [absent/present].
Treatment Protocol
Recommended procedure: Primary MTF breast augmentation via [incisional approach: inframammary/periareolar]. Implant selection: [type: silicone/saline], [volume: cc], [profile: high/moderate]. Placement: [submuscular/dual-plane]. Intraoperative considerations include [capsular release/asymmetry correction]. Post-operative plan: [compression garment/drainage/follow-up schedule].